# Cancer Immunotherapy and Biomarkers

{
  "id": "T10158",
  "title": "Cancer Immunotherapy and Biomarkers",
  "url": "/topics/T10158",
  "kind": "topic-directory",
  "aeo_cohort": "topic-directory",
  "provider": "openalex",
  "revision": "8e61cf212aea90e1",
  "catalogue_revision": "f050b5d4780b1289",
  "numeric_address": "36108824083622370",
  "address_version": "morton4x16-v1",
  "coordinates": [
    4,
    27,
    2730,
    10158
  ],
  "answer_status": "Directory metadata; local answer requires separate source review",
  "truth_status": "Subject descriptor, not a factual answer or a demonstrated knowledge gap"
}

This cluster of papers focuses on the advances in cancer immunotherapy research, particularly in the context of immune checkpoint blockade targeting PD-1 and PD-L1, the impact of tumor microenvironment, biomarkers for immunotherapy response, T-cell exhaustion, neoantigens, tumor mutational burden, immune-related adverse events, and the exploration of combination therapies. The research also delves into the intricate mechanisms of cancer immunoediting.

Directory metadata is not a factual answer or evidence of a global knowledge gap.

Source: https://openalex.org/T10158

No owner-reviewed local answer yet.